Luke E. Zabotka

464 total citations
6 papers, 29 citations indexed

About

Luke E. Zabotka is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Luke E. Zabotka has authored 6 papers receiving a total of 29 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Epidemiology, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in Luke E. Zabotka's work include Retinal and Optic Conditions (1 paper), Retinal Imaging and Analysis (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Luke E. Zabotka is often cited by papers focused on Retinal and Optic Conditions (1 paper), Retinal Imaging and Analysis (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). Luke E. Zabotka collaborates with scholars based in United States and Germany. Luke E. Zabotka's co-authors include Shirley Wang, José J. Hernández‐Muñoz, Sharon E. Davis, Judith C. Maro, Joshua Smith, Nigam H. Shah, Kevin Coughlin, Rishi Desai, Sebastian Schneeweiß and Helen Tesfaye and has published in prestigious journals such as Journal of Clinical Epidemiology, Journal of General Internal Medicine and Drug Safety.

In The Last Decade

Luke E. Zabotka

6 papers receiving 29 citations

Peers

Luke E. Zabotka

TOXIC

MB

EDM

AI

PHEOH

Lisanne E. N. Manson Netherlands

S. Bright United States

Clare Prince United Kingdom

Laura Ruppert United States

Jamie Malloy United States

Nguyen Thi Diem Vietnam

Alisha J Smith United States

Dylan Hodgkiss United Kingdom

Salwa Naushin India

Kristina S. Wickham United States

Lisanne E. N. Manson Netherlands

Luke E. Zabotka

5 ×0.6

TOXIC

4 ×0.6

MB

0 ×0.0

EDM

0 ×0.0

AI

1 ×0.3

PHEOH

Citations per year, relative to Luke E. Zabotka Luke E. Zabotka (= 1×) peers Lisanne E. N. Manson

Countries citing papers authored by Luke E. Zabotka

Since Specialization

Citations

This map shows the geographic impact of Luke E. Zabotka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke E. Zabotka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke E. Zabotka more than expected).

Fields of papers citing papers by Luke E. Zabotka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke E. Zabotka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke E. Zabotka. The network helps show where Luke E. Zabotka may publish in the future.

Co-authorship network of co-authors of Luke E. Zabotka

This figure shows the co-authorship network connecting the top 25 collaborators of Luke E. Zabotka. A scholar is included among the top collaborators of Luke E. Zabotka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke E. Zabotka. Luke E. Zabotka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Tesfaye, Helen, Luke E. Zabotka, Deborah J. Wexler, et al.. (2024). Empagliflozin and Risk of Incident Gout: Analysis from the EMPagliflozin Comparative Effectiveness and SafEty (EMPRISE) Cohort Study. Journal of General Internal Medicine. 39(10). 1870–1879. 3 indexed citations

2.

Yoshida, Kazuki, Tianrun Cai, Lily G. Bessette, et al.. (2023). Improving the accuracy of automated gout flare ascertainment using natural language processing of electronic health records and linked Medicare claims data. Pharmacoepidemiology and Drug Safety. 33(1). e5684–e5684. 1 indexed citations

3.

Davis, Sharon E., Luke E. Zabotka, Rishi Desai, et al.. (2023). Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review. Drug Safety. 46(8). 725–742. 17 indexed citations

4.

Schneeweiß, Sebastian, Sushama Kattinakere Sreedhara, Luke E. Zabotka, et al.. (2022). Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety. JNCI Cancer Spectrum. 6(4). 5 indexed citations

5.

Roh, Miin, Helen Tesfaye, Seoyoung C. Kim, Luke E. Zabotka, & Elisabetta Patorno. (2022). Cardiovascular and Mortality Risk with Intravitreal Vascular Endothelial Growth Factor Inhibitors in Patients with Diabetic Retinopathy. Ophthalmology Retina. 6(12). 1145–1153. 1 indexed citations

6.

Lin, Kueiyu Joshua, William B. Feldman, Shirley Wang, et al.. (2022). Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies. Journal of Clinical Epidemiology. 151. 45–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact